Stuart Levitz to Amphotericin B
This is a "connection" page, showing publications Stuart Levitz has written about Amphotericin B.
Connection Strength
0.566
-
Levitz SM, Shoham S, Cleary JD. Toll-like receptor 4 polymorphisms and aspergillosis. N Engl J Med. 2009 Feb 05; 360(6):634; author reply 635-6.
Score: 0.314
-
Sau K, Mambula SS, Latz E, Henneke P, Golenbock DT, Levitz SM. The antifungal drug amphotericin B promotes inflammatory cytokine release by a Toll-like receptor- and CD14-dependent mechanism. J Biol Chem. 2003 Sep 26; 278(39):37561-8.
Score: 0.214
-
McQuillen DP, Zingman BS, Meunier F, Levitz SM. Invasive infections due to Candida krusei: report of ten cases of fungemia that include three cases of endophthalmitis. Clin Infect Dis. 1992 Feb; 14(2):472-8.
Score: 0.024
-
Levitz SM, Diamond RD. Changing patterns of aspergillosis infections. Adv Intern Med. 1984; 30:153-74.
Score: 0.014